What was the physiological, safety, and compliance-focused rationale for combining basal insulin plus GLP-1 RA into a fixed ratio formulation?

What was the physiological, safety, and compliance-focused rationale for combining basal insulin plus GLP-1 RA into a fixed ratio formulation?

What was the physiological, safety, and compliance-focused rationale for combining basal insulin plus GLP-1 RA into a fixed ratio formulation?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Silvio Inzucchi, MD

Silvio Inzucchi, MD

Professor of Medicine (Endocrinology) Clinical Director, Section of Endocrinology Director, Yale Diabetes Center Director, Endocrinology & Metabolism Fellowship New Haven, Connecticut